A highly efficient gene-cloning system for Micromonospora olivasterospora, a producer of the antibiotic fortimicin A (astromicin), suited to shotgun cloning has been developed. The system is supported by two new advancements accomplished in this study. One is the construction of novel plasmid vectors pMO116, pMO126, pMO133, pMO136, and pMO217, all consisting of replicons from newly found Micromonospora plasmids and selectable markers cloned from a neomycin-producing Micromonospora strain. The other advancement is the establishment of a new protocol for bacterial protoplasting in which some kinds of sugar alcohols are added in precultures. Such sugar alcohols were found to sensitize a wide taxonomical range of bacteria to lysozyme. The system is reproducible and reliable and has a high efficiency of more than 106 CFU/,ug of DNA.
Despite the wide distribution of industrially important attributes in actinomycetes, practical and reliable genecloning systems for these bacteria, other than Streptomyces strains, have not been established. Development of such systems for Micromonospora strains has been especially desired because the genus includes industrially valuable strains for the production of gentamicins (10) , sagamicins (17) , sisomicins (24) , and fortimicin A (astromicin) (14) . In addition, the genus is still one of the most important targets in screening programs of pharmacologically active compounds.
The cloning of several Micromonospora genes (4, 22) and promoters (1) by using Streptomyces systems had been reported. But it is more desirable to develop systems which allow us to express Micromonospora genes in the homologous backgrounds. Studies so far have applied ready-made Streptomyces vectors to Micromonospora hosts (4, 7, 12) . These trials failed to establish reproducible and efficient cloning systems suited for shotgun cloning. Even simple DNA manipulation seemed to be difficult with such systems because of the extreme instability of Streptomyces vectors in Micromonospora strains. As we report here, we tried to develop a Micromonospora cloning system by using plasmid vectors constructed from Micromonospora replicons. Micromonospora plasmids were screened first, and the newly found plasmids of M. olivasterospora were used in the vector construction along with the selectable markers cloned from a neomycin-producing Micromonospora strain. We also developed a new protoplasting protocol applicable to lysozyme-resistant bacteria. The combination of our new Micromonospora vectors, our efficient protoplasting protocol, and special regeneration media enabled us to develop a Micromonospora gene-cloning system of high efficiency sufficient for shotgun cloning.
MATERIALS AND METHODS
Bacterial strains and plasmids. Lyophilized stock cultures and fresh isolates of Micromonospora strains, including M. olivasterospora (14) , were used in the plasmid screening. Streptomyces lividans TK23 (10) and plasmids pIJ61 (2), * Corresponding author. pIJ702 (5) , and pEN101 (16) were employed as the controls for our novel Micromonospora system.
Media for bacterial growth. Micromonospora strains were maintained on modified ATCC no. 5 medium consisting of Stabirose K (1%, wt/vol; Matsutani Kagaku Kogyo, Hyogo, Japan), tryptose (0.2%; Difco), yeast extract (0.1%; Nippon Seiyaku, Tokyo), beef extract (0.1%; Difco), FeSO4. 7H20 (0.01%), and Bacto Agar (2%; Difco), pH 7.8 . The composition of SK no. 2 medium (pH 7.6) for liquid cultures was Stabirose K (2%), glucose (0.5%), yeast extract (0.5%), peptone (0.5%; Nippon Seiyaku), meat extract (0.3%; Nippon Seiyaku), KH2PO4 (0.02%), and MgSO4. 6H20 (0.06%). Neomycin B sulfate (Sigma; 2.5 ,ug/ml for agar plates and 0.5 ,ug/ml for liquid cultures) was added if necessary. Other antibiotics were also purchased from Sigma with the exception of thiopeptin (Shionogi Pharmaceuticals, Osaka, Japan).
Screening of Micromonospora plasmids. Low-and highcopy-number plasmids were screened with mycelia grown at 30°C in 10 ml of SK no. 2 medium. The standard minipreparation method of Kieser (8) was modified and used for plasmid extraction, in which a higher concentration of lysozyme (5 mg/ml; Seikagaku Kogyo Co., Tokyo) was used. Extracted plasmids were dissolved in 250 ,lI of TE buffer (11) , and aliquots of 30 p,l were subjected to agarose gel electrophoresis. Copy numbers of plasmids were estimated by the method of Kieser et al. (9) .
Construction of Micromonospora vectors. Preparative-scale isolation of plasmids of M. zionensis NRRL 5466, M. halophytica subsp. nigra ATCC 33088, and the two strains of M. olivasterospora (ATCC 31010 and KY11070) was performed in a 1-liter culture of each strain by the method described above and then by further purification with ethidium bromide-CsCl density gradient ultracentrifugation. According to the method of Maniatis et al. (11) , approximately 1 p,g of purified plasmids was digested with BamHI, BglII, or BclI and ligated at 15°C with ca. 0.3 p.g of a 2.9-kb BglII fragment of Micromonospora sp. strain MK50 containing a neomycin resistance gene, nmrA (1Sa), in 25 plI of ligation buffer, using 1 U of T4 ligase. Twenty microliters of the mixture was combined with 80 plI of P medium (2) and 100 pAl of a protoplast suspension of M. olivasterospora ATCC 21819 (1.1 x 109 microscopically visible protoplasts per ml); this GENE-CLONING SYSTEM FOR MICROMONOSPORA STRAINS 7005 combination was allowed to stand for 1 min at room temperature and then was gently mixed with 800 jxl of 25% polyethylene glycol 1000 (PEG 1000; Nakarai Tesq, Tokyo) in T medium (2) . Regeneration and selection of transformants were done as described below. To construct a derivative vector of pMO116, pMO126 conveying neomycin resistance gene nmrB, 0.4 ,ug of pMO116 digested with BamHI plus BglII was treated with 0.1 U of calf intestinal alkaline phosphatase and then ligated with ca. 0.2 pgg of an nmrBcontaining BamHI fragment (3.1 kb) of Micromonospora sp. strain MK50. A second derivative vector, pMO136, was constructed by using a SacI-plus-BclI digest of pMO116 and a BamHI-SacI fragment (1.5 kb) containing nmrB. In these derivation procedures, the optimized transformation conditions for Micromonospora strains (see below) were used. T4 ligase (Takara, Kyoto, Japan) and restriction enzymes and calf intestinal alkaline phosphatase (Boehringer Mannheim) were used in the buffers described by Davis et al. (3) and those recommended by the suppliers.
New protocol for bacterial protoplasting. Spores or frozen stock mycelia in 20% glycerol were inoculated in 4 ml of SK no. 2 medium and cultured to full growth at 30°C for 2 to 3 days. Portions (0.2 to 0.3 ml) of such cultures were transferred to 30 ml of SK no. 2 medium containing D-mannitol (3.3 to 10%, wt/vol), D-sorbitol (3.3 to 5.0%), or D-arabitol (3.3 to 5.0%) and grown to the early stationary phase. For M. olivasterospora, 5 .0% D-mannitol was routinely used. Mycelia were collected, washed in P medium, and then incubated in 10 ml of the same medium with lysozyme (10 mg/ml) at 37°C. Protoplasts were spun down at 1,800 x g and 4°C for 5 min. Supernatants were removed by pipetting, and protoplasts were washed twice with cold P medium. Purified protoplasts were resuspended in 2 ml of the same medium and stored at -80°C.
Transformation and regeneration of Micromonospora protoplasts. At the initial stage of this study to construct the original Micromonospora vectors pMO116, pMO133, and pMO217, the protocol for Streptomyces strains (2) was employed. In our optimized conditions for Micromonospora strains, TM+ medium was used instead of the T medium used for Streptomyces strains. The medium was prepared by mixing 90 ml of TM-medium (sucrose, 16.5 g; K2S04, 0.04 g; MgSO4 6H20, 0.34 g; trace element solution [2] , 0.33 ml), 10 ml of 0.25 M TES (Good buffer; Nakarai Tesq) ( Selection of transformants. Two alternative methods were used to select transformants. In the soft agar overlay method, we overlaid with 2.5 ml of soft agar (kept at 40°C) of the same composition as modified ATCC no. 5, with the exception of the presence of 6% (wt/vol) D-mannitol, 0.4 mg of neomycin B sulfate per ml, and a lower concentration of Bacto Agar (0.5%). In the second method, the direct selection method, we generated the selection pressure by plating 100 ,ul of P medium containing 1 mg of neomycin B sulfate by using glass rods just 1 day after plating the protoplasts. After such treatments, the plates were resealed and incubated further for 2 to 3 weeks.
RESULTS AND DISCUSSION
Trials to construct gene-cloning systems for actinomycetes other than Streptomyces strains have been reported so far for Micromonospora strains (7, 12) , Saccharopolyspora strains (25) , Thermomonospora strains (20) , and Amycolatopsis strains (13) sized plasmid of about 10.5 kb. Coelectrophoresis on agarose gels revealed that the plasmids of these three strains are all identical. On the other hand, the size of the plasmid in strain ATCC 31010 was obviously different from those of the other strains. Thus, the strains of M. olivasterospora that we studied proved to harbor at least three different types of plasmids. We called them pMO101 (the plasmid of strain ATCC 31010) and pMO201 and pMO301 (the larger and smaller plasmids of the three strains KY11068, KY11069, and KY11070, respectively). Although the copy number of pMO101 was stably maintained during cultivation up to 72 h, those of pMO201 and pMO301 were not. pMO301 was extremely unstable and could be seen only in 24-h cultivation. Thus, we chose pMO101 and pMO201 as the candidate materials for vector construction. The physical map of pMO101 is shown in Fig. 1C The strain was highly resistant (MIC _ 150 gg/ml) not only to the self-antibiotic fortimicin A but also to gentamicins, kanamycins, and spectinomycin. As the strain was sensitive (MIC ' 2.5 gg/ml) to neomycin B, streptomycin, and thiopeptin, resistance genes to these antibiotics were thought to be proper selectable markers of the vectors for the strain. To make cloning systems of generically homologous backgrounds, we wanted markers originating from Micromonospora strains. We had cloned and characterized two kinds of neomycin resistance genes, nmrA and nmrB, from a neomycin producer, Micromonospora sp. strain MK50 (1Sa) and had shown that nmrA coded for neomycin phosphotransferase of the APH(3')II type and that nmrB might conduct ribosomal modification. The DNA fragments containing these genes were used to construct our Micromonospora vectors (Fig. 2) .
To make chimeric plasmids harboring nmrA, we digested pMH101, pMZ201, and pMO101 with BamHI, BglIl, or Bcll completely or partially. The complicated mixture of the restricted DNA fragments of pMO201mix generated by various restriction enzymes was directly used because we assumed that some of these fragments might contain replication origins and machineries for stable inheritance in M. olivasterospora. The 2.9-kb BglII fragment of Micromonospora sp. strain MK50 which contained nmrA (Fig. 2) was ligated with these digested plasmids and introduced into the protoplasts of M. olivasterospora ATCC 21819 with the assistance of PEG 1000 by the method used for the S. lividans system (2) . Although the procedure was of extremely low efficiency in Micromonospora strains, 5 to 30 neomycin-resistant regenerants were obtained in a single experiment. With pMH101 and pMZ201, potential chimeric plasmids of the expected sizes were detected on agarose gels by using the minipreparation of plasmids (8) from the firstround cultivations of the primary protoplast regenerants. But during the second cultivation in preparative scale for the structural determination of these plasmids, they were completely lost from the cells even under high selection pressure from neomycin B.
In contrast, we could obtain several stable chimeric plasmids from pMO101 and pMO201mix. From the neomycinresistant transformants of M. olivasterospora, three chimeric plasmids, pMO116, pMO133, and pMO217, were isolated, and their structures were examined. pMO133 (22.4 kb) was found to consist of a 19.6-kb BclI fragment of pMO101 ( Fig. 1) and a BglII fragment of strain MK50 harboring nmrA (Fig. 2) . As this chimeric plasmid possesses a unique BclI site in the nonessential DNA region from strain MK50, the site is thought to be useful as a cloning site. Thus, the Bcll fragment of 19.6 kb is thought to harbor the replication origin of pMO101. In contrast, the chimeric plasmid pMO116 (6.9 kb) had no easily understandable structure (Fig. 2) . Although complete digests of pMO101 by BclI were used in this construction, none of the full-length BclI fragments in pMO101 were seen in pMO116. It was found that this plasmid kept most of the 2.9-kb BglII fragment of strain MK50 but lacked the part containing the BamHI site adjacent to the BglII site at one end (Fig. 2) .
Moreover, an unexplained BglII site was found in pMO116 (Fig. 2, at characteristic linked XbaI-XhoI sites at a 0.2-kb distance. This was also true in pMO116 and pMO133. This fact suggested that this part in pMO116 came from pMO101. This idea was confirmed by a Southern blot analysis of pMO101 with 32P-labeled pMO116 as a hybridization probe (data not shown). It suggested also that this unique part carried the replication origin of pMO101. The small size (6.9 kb) and some unique restriction sites for BglII, BclI, and KpnI of pMO116 suggested the usefulness of the plasmid as a cloning vector. The biosynthetic genes of fortimicin A in fact have been cloned by using this plasmid vector (unpublished data). Only a single product was obtained in the vector construction using pMO201mix. The structure of plasmid pMO217 (12.6 kb, Fig. 2 ) indicated that it came from the 9.7-kb BglII fragment of pMO201mix and the 2.9-kb fragment of Micromonospora sp. strain MK50. A unique site, SphI, seemed to be useful as a cloning site.
Copy numbers of new vectors. Copy numbers of pMO116, pMO133, and pMO217 were measured by the conventional method of Kieser et al. (9) . They were estimated to be between 10 and 20 per genome when the transformants were grown in SK no. 2 medium.
Construction of derivative vectors of pMO116. pMO116 was chosen to make derivative vectors harboring various cloning sites other than those on pMO116 itself. In this construction, the optimized transformation conditions for M. olivasterospora described below were used. The parts of the nmrA-containing DNA fragment in pMO116 were replaced with nmrB-containing DNA fragments which came also from Micromonospora sp. strain MK50. Complete digestion of pMO116 with BamHI and BglII, introduction of the nmrB-containing BamHI fragment (3.1 kb, Fig. 2) , and subsequent transformation of M. olivasterospora gave a new vector, pMO126, 7.3 kb in size, with potential cloning sites BamHI, BclI, Sacl, and SphI. A second new derivative vector, pMO136 (7.3 kb), was constructed by using the SacI-BclI digest of pMO116 and the nmrB-containing BamHI-SacI fragment (1.5 kb, Fig. 2 For Micromonospora strains, this had always been one of the serious problems (7, 12) because the protocols for Streptomyces strains (2, 18) were not directly applicable to Micromonospora, strains. This was also true for M. olivasterospora, which is extraordinarily resistant to lysozyme because of the glycolylated muraminic acid in its cell walls (6) . Protoplasting by use of this enzyme was never completed, even after prolonged incubation of more than several hours (Fig. 3, row A) . Protoplasts obtained with difficulty through such a process were extremely labile, and their recovery fluctuated severely. Trials applying another lytic enzyme, achromopeptidase (Wako Junyaku, Tokyo), which had been used for a lysozyme-resistant strain of Streptomyces hygroscopicus (15) , resulted in no protoplasting.
We found that the morphology of M. olivasterospora in liquid cultures was dramatically affected when the strain was grown in the presence of some kinds of sugar alcohols. The hyphae became rather thick, and some parts, especially apexes, swelled or formed bulges, although no structural changes in the cell surface were observed by electron microscopy. Very interestingly, these hyphae were revealed to be highly sensitive to lysozyme. The addition of a small amount of glycine (less than 0.3%, wt/vol) in precultures made hyphae more sensitive but was not always necessary. Figure 3 shows the effects of the addition of D-mannitol to precultures. Protoplasting of the mycelia from cultures with 5% D-mannitol was completed within only 90 min. We could skip filtration of protoplasts to remove remaining mycelia because of the completeness of the new process. D-Sorbitol and D-arabitol were also found to accelerate protoplasting. The optimum concentrations depended on the types of these alcohols and were usually below 10lo (Table 1) . No effects were observed for xylitol, adonitol, dulcitol, and D-glycerol (data not shown). The density of microscopically visible protoplasts obtained by the established method was about 5 x 1010 to 8 x 1010/ml. Such protoplast preparations were e In the control experiment, no sugar alcohols were added but 0.3% (wt/vol) glycine was added to the preculture. Mycelia were collected from a 64-h-old culture.
f Protoplasting was not completed in 5 h. Residual mycelia were removed by double filtration through cotton wool. g The ratio of regeneration on RM2 fluctuated between 0 and 0.5%.
very stable and could be stored at -80°C for at least 4 months without significant loss of viability.
The mechanism of action of these sugar alcohols is not clear. The dependency of the effect of these alcohols on their own structures means that their physiological function rather than physical effects like osmotic pressure is important. At these concentrations, the growth of M. olivasterospora is not inhibited or is inhibited only slightly. What is important is that this remarkable effect of sugar alcohols is not limited to Micromonospora strains. For example, Streptomyces sannanensis, a sannamycin producer resistant to lysozyme even after glycine pretreatment, could be completely protoplasted by our method (15a). Furthermore, we found that not only actinomycetes but also some other gram-positive bacteria (like Corynebacterium and Brevibacterium species) known to be highly resistant to lysozyme were sensitized by the method (data not shown). Thus, the method presented here must have wide application for bacterial protoplasting.
Regeneration of protoplasts. Protoplasts of M. olivasterospora did not regenerate on regeneration media generally used for Streptomyces strains. The prototype regeneration medium RM1 was designed by considering the composition of modified ATCC no. 5 medium, in which the strains grew well. The regeneration ratio (ratio of numbers of regenerated colonies to numbers of plated, microscopically visible protoplasts) on RM1 was very low (usually below 0.1%) and fluctuated severely (0 to 1%). Several parameters were examined to try to improve and stabilize the ratio.
The sizes of regenerated colonies were well normalized by the addition of 0.25% (wt/vol) bovine serum albumin to RM1 medium. The addition of a small amount of supernatant of the sonicate of M. olivasterospora increased the regeneration ratio by several times, although regenerated colonies still remained very small, especially when protoplasts were plated at high density. A shortage of unknown requirements for regeneration might be overcome by the addition of the supernatant. The most important parameter in the regener- As osmotic stabilizers, both 10% sucrose and 10% D-mannitol worked very well. We preferred the latter because it somehow prevented fungal contamination during the rather long protoplast regeneration period (2 to 3 weeks) resulting from the slow growth of Micromonospora strains. As for Streptomyces strains, the water content of regeneration plates severely affected the ratio. Brief drying of about 20 min in laminar flow (about 3% reduction of medium weight) was found to give the best results. The RM2 medium thus established provided us with a regeneration ratio of 8 to 35%. This ratio is excellent when compared with the results of Szvoboda et al. (-0.1%) (21) .
Transformation of Micromonospora strains. The experiments for the construction of vectors described above indicated that the PEG-assisted protocol for Streptomyces strains worked somehow in M. olivasterospora. We optimized the transformation conditions with our pMO series vectors developed in this study.
Because the protoplasts of Micromonospora strains were fragile in comparison with those of Streptomyces strains, the concentrations of divalent cations and osmotic stabilizers had to be carefully maintained. Thus, their concentrations were raised to higher levels in TM medium to prevent the dilution of these components by the mixing with PEG. Among the PEGs (final concentration, 20%, vol/vol) tested, PEG 2000 gave the best results in transformation. As shown in Table 2 p.g neomycin B per ml, grown for a week, and then checked for plasmids.
Transformation efficiency. The transformation efficiency of each of our vectors is shown in Table 2 (experiment 2). The efficiency of our Micromonospora system was more than 106 CFU/p.g of DNA and is very comparable to that of the S. lividans system (2) . Such high efficiencies indicate that our novel system is suited to shotgun cloning of Micromonospora genes. In contrast, Streptomyces vectors pIJ61, pIJ702, and pEN101 had no or very low transformation efficiencies (below 102 CFU/gu.g of DNA) and were found to be extremely unstable in M. olivasterospora (data not shown).
Stability of vectors. The strain harboring pMO116 was passaged through three cycles of sporulation and germination on modified ATCC no. 5 plates in the presence or absence of neomycin B. At each cycle, spores were collected and checked for the presence of plasmids by plating them on the above plates with or without neomycin B. The plasmid was almost perfectly maintained in the presence of the antibiotic. The loss of the plasmid in the absence of the antibiotic was not very significant, and more than 70% of the spores kept the vector even after three life cycles (data not shown).
We believe that this is the first report on the development of a practical gene-cloning system, capable of use for shotgun cloning, for Micromonospora strains. The application of this system to the cloning of the biosynthetic genes of fortimicin A will be reported soon.
